Sort   by:  
 Page size 
UnknownTRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.
Not available
S-EPMC3372437 | biostudies-literature
UnknownChymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.
Not available
S-EPMC2650829 | biostudies-literature
UnknownAddition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.
Not available
S-EPMC9606085 | biostudies-literature
UnknownA degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis.
Not available
S-EPMC2746914 | biostudies-literature
UnknownRare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Not available
S-EPMC11246049 | biostudies-literature
Sort   by:  
 Page size